Pfizer gets USFDA approval for second biosimilar of Remicade Ruby Khatun Khatun18 Dec 2017 4:45 AM GMTThe U.S. Food and Drug Administration approved Pfizer Inc's second biosimilar to Johnson and Johnson's blockbuster rheumatoid arthritis drug,...